Navigation
Home
Advocating for Access
Background
Letters for Access
Press Releases For Access
Simplified Community Materials
Simplified Community Materials
Understanding your HCV infection
Community Led Reports
Country Information
Indonesia
India
Vietnam
Generic DAAs Pricing
Resources
Guidelines
Key Research Publication
Other Important Documents and Reports
News
Gallery
Photos
Video
Stories
The use of generic DAAs for hepatitis C treatment, Freeman et al 2016
The use of generic DAAs for hepatitis C treatment, Freeman et al 2016
Download PDF
June 28, 2016
/
News
Share
the Post
Related
Posts
Pricing and availability of generic Indian daclatasvir as on 7 March 2016
Patent Situation of The Key Product For Treatment of Hepatitis C: SOFOSBUVIR – WHO working paper, updated 2015
Hepatitis C Treatment Snapshots: Daclatasvir
Four Indian generic companies take sub license from MPP on daclatasvir
Asia Pacific Situational Updates on Generic DAAs – June 2017
Strategies to Secure Access to Generic HCV Medicines
Generic daclatasvir (60 mg) availability and India market pricing as of 30 January 2016
BMS’ patent bid for Hep C treatment Daclatasvir Challenged
